Bausch + Lomb Corporation (BLCO) Stock
Fundamentals
Latest news
About Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Brenton L. Saunders J.D. | CEO & Director | 1970 |
| Mr. Osama A. Eldessouky | Executive VP & CFO | 1972 |
| Mr. A. Robert D. Bailey | Executive VP & Chief Legal Officer | 1963 |
| Dr. Yehia Hashad M.D., Ph.D. | Executive VP of Research & Development and Chief Medical officer | 1968 |
| Mr. Andrew J. Stewart | President of Global Pharmaceuticals & International Consumer | 1976 |
| Mr. Alan Waterhouse CPFA, MBA | Executive VP and Chief Supply Chain & Operations Officer | 1960 |
| Mr. Frederick J. Munsch | Senior VP, Controller & Chief Accounting Officer | 1970 |
| Mr. George Gadkowski | VP & Head of Investor Relations & Business Insights | — |
| Mr. Jonathon L. Kellerman | Chief Compliance Officer | — |
| Mr. T.J. Crawford | Chief Communications Officer | — |



